- $17.97bn
- $14.43bn
- $5.14bn
Annual cashflow statement for Incyte, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 949 | 341 | 598 | 32.6 | 1,287 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 223 | 306 | 224 | 161 | 313 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -14.6 | 199 | -249 | 138 | -527 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 749 | 970 | 496 | 335 | 1,413 |
| Capital Expenditures | -181 | -77.8 | -32.5 | -86.3 | -58.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -26.7 | -0.709 | -175 | 244 | -43.7 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -208 | -78.5 | -208 | 158 | -103 |
| Financing Cash Flow Items | -50 | -59 | -52.5 | -62.3 | -116 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.18 | -0.794 | -20 | -2,022 | 101 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 544 | 894 | 262 | -1,526 | 1,410 |